United Therapeutics Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | Outperform |
9
|
$149.92 | $174.55 | 13.39% | 3 | $360.81B |
| PFE | Pfizer | Outperform |
2
|
$27.70 | $32.87 | 10.11% | 6 | $156.85B |
| AMGN | Amgen | Outperform |
4
|
$278.39 | $303.65 | 14.77% | 8 | $149.32B |
| VRTX | Vertex Pharmaceuticals Inc | Outperform |
12
|
$400.16 | $457.59 | 12.83% | 11 | $103.43B |
| REGN | Regeneron Pharmaceuticals | Outperform |
2
|
$937.61 | $961.26 | 11.99% | 8 | $101.15B |
| GSK | GSK | Outperform |
12
|
£17.29 | £17.30 | 12.78% | 12 | £70.49B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$65.33 | $87.82 | 22.46% | 14 | $81.46B |
| BIIB | Biogen | Outperform |
10
|
$213.51 | $299.62 | 35.12% | 13 | $31.09B |
| BAYN | Bayer | Hold |
5
|
28.13€ | 45.15€ | 6.65% | 4 | 27.64€B |
| CE | Celanese | Hold |
13
|
$156.38 | $148.23 | 2.31% | 18 | $17.45B |
| VTRS | Viatris Inc | Hold |
8
|
$11.60 | $11.73 | 7.76% | 5 | $13.74B |
| LQDA | Liquidia | Outperform |
6
|
$12.98 | $19.71 | 123.42% | 2 | $981.52M |